vs
巴里克黄金（B）与奎斯特诊断（DGX）财务数据对比。点击上方公司名可切换其他公司
巴里克黄金的季度营收约是奎斯特诊断的1.3倍（$3.7B vs $2.9B），巴里克黄金净利率更高（34.1% vs 9.7%，领先24.4%），巴里克黄金同比增速更快（16.4% vs 9.2%）
巴里克黄金是一家主营黄金、铜开采生产的矿业企业，业务布局覆盖阿根廷、加拿大、智利、刚果（金）等全球近二十个国家和地区。2024年该公司黄金产量达391万盎司，全维持成本为每盎司1484美元；铜产量19.5万吨，全维持成本为每磅3.45美元。
奎斯特诊断是美国头部临床检验服务商，位列《财富》500强，业务覆盖美国、波多黎各、墨西哥及巴西，同时与全球范围内多家医院、诊所保持长期协作关系，为不同地区的客户提供专业临床检验相关服务。
B vs DGX — 直观对比
营收规模更大
B
是对方的1.3倍
$2.9B
营收增速更快
B
高出7.3%
9.2%
净利率更高
B
高出24.4%
9.7%
损益表 — Q2 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.7B | $2.9B |
| 净利润 | $1.3B | $281.0M |
| 毛利率 | 49.0% | — |
| 营业利润率 | 38.5% | 15.4% |
| 净利率 | 34.1% | 9.7% |
| 营收同比 | 16.4% | 9.2% |
| 净利润同比 | 98.1% | 12.0% |
| 每股收益（稀释后） | $0.47 | $2.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BDGX
| Q1 26 | — | $2.9B | ||
| Q4 25 | — | $2.8B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | $3.7B | $2.8B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | $3.2B | $2.4B |
净利润BDGX
| Q1 26 | — | $281.0M | ||
| Q4 25 | — | $245.0M | ||
| Q3 25 | — | $245.0M | ||
| Q2 25 | $1.3B | $282.0M | ||
| Q1 25 | — | $220.0M | ||
| Q4 24 | — | $222.0M | ||
| Q3 24 | — | $226.0M | ||
| Q2 24 | $634.0M | $229.0M |
毛利率BDGX
| Q1 26 | — | — | ||
| Q4 25 | — | 32.4% | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | 49.0% | 34.2% | ||
| Q1 25 | — | 32.5% | ||
| Q4 24 | — | 32.7% | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | 37.4% | 33.5% |
营业利润率BDGX
| Q1 26 | — | 15.4% | ||
| Q4 25 | — | 13.8% | ||
| Q3 25 | — | 13.7% | ||
| Q2 25 | 38.5% | 15.9% | ||
| Q1 25 | — | 13.0% | ||
| Q4 24 | — | 13.8% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | 34.5% | 14.8% |
净利率BDGX
| Q1 26 | — | 9.7% | ||
| Q4 25 | — | 8.7% | ||
| Q3 25 | — | 8.7% | ||
| Q2 25 | 34.1% | 10.2% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | — | 9.1% | ||
| Q2 24 | 20.1% | 9.6% |
每股收益（稀释后）BDGX
| Q1 26 | — | $2.24 | ||
| Q4 25 | — | $2.18 | ||
| Q3 25 | — | $2.16 | ||
| Q2 25 | $0.47 | $2.47 | ||
| Q1 25 | — | $1.94 | ||
| Q4 24 | — | $1.95 | ||
| Q3 24 | — | $1.99 | ||
| Q2 24 | $0.21 | $2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.8B | $393.0M |
| 总债务越低越好 | — | $5.7B |
| 股东权益账面价值 | $33.4B | $7.7B |
| 总资产 | $47.3B | $16.7B |
| 负债/权益比越低杠杆越低 | — | 0.74× |
8季度趋势，按日历期对齐
现金及短期投资BDGX
| Q1 26 | — | $393.0M | ||
| Q4 25 | — | $420.0M | ||
| Q3 25 | — | $432.0M | ||
| Q2 25 | $4.8B | $319.0M | ||
| Q1 25 | — | $188.0M | ||
| Q4 24 | — | $549.0M | ||
| Q3 24 | — | $764.0M | ||
| Q2 24 | $4.0B | $271.0M |
总债务BDGX
| Q1 26 | — | $5.7B | ||
| Q4 25 | — | $5.2B | ||
| Q3 25 | — | $5.2B | ||
| Q2 25 | — | $5.2B | ||
| Q1 25 | — | $5.9B | ||
| Q4 24 | — | $5.6B | ||
| Q3 24 | — | $5.6B | ||
| Q2 24 | — | $3.8B |
股东权益BDGX
| Q1 26 | — | $7.7B | ||
| Q4 25 | — | $7.2B | ||
| Q3 25 | — | $7.3B | ||
| Q2 25 | $33.4B | $7.2B | ||
| Q1 25 | — | $6.9B | ||
| Q4 24 | — | $6.8B | ||
| Q3 24 | — | $6.8B | ||
| Q2 24 | $32.5B | $6.6B |
总资产BDGX
| Q1 26 | — | $16.7B | ||
| Q4 25 | — | $16.2B | ||
| Q3 25 | — | $16.2B | ||
| Q2 25 | $47.3B | $16.0B | ||
| Q1 25 | — | $15.8B | ||
| Q4 24 | — | $16.2B | ||
| Q3 24 | — | $16.1B | ||
| Q2 24 | $46.2B | $13.9B |
负债/权益比BDGX
| Q1 26 | — | 0.74× | ||
| Q4 25 | — | 0.72× | ||
| Q3 25 | — | 0.71× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 0.85× | ||
| Q4 24 | — | 0.83× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | 0.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $278.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 3.9% |
| 现金转化率经营现金流/净利润 | 1.06× | 0.99× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BDGX
| Q1 26 | — | $278.0M | ||
| Q4 25 | — | $465.0M | ||
| Q3 25 | — | $563.0M | ||
| Q2 25 | $1.3B | $544.0M | ||
| Q1 25 | — | $314.0M | ||
| Q4 24 | — | $464.0M | ||
| Q3 24 | — | $356.0M | ||
| Q2 24 | $1.2B | $360.0M |
自由现金流BDGX
| Q1 26 | — | — | ||
| Q4 25 | — | $307.0M | ||
| Q3 25 | — | $419.0M | ||
| Q2 25 | — | $436.0M | ||
| Q1 25 | — | $197.0M | ||
| Q4 24 | — | $341.0M | ||
| Q3 24 | — | $250.0M | ||
| Q2 24 | — | $268.0M |
自由现金流率BDGX
| Q1 26 | — | — | ||
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 15.8% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | — | 11.2% |
资本支出强度BDGX
| Q1 26 | — | 3.9% | ||
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 4.4% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 4.3% | ||
| Q2 24 | — | 3.8% |
现金转化率BDGX
| Q1 26 | — | 0.99× | ||
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 2.30× | ||
| Q2 25 | 1.06× | 1.93× | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | 2.09× | ||
| Q3 24 | — | 1.58× | ||
| Q2 24 | 1.83× | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
